Apollon Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.21M | Sell |
46,578
-2,614
| -5% | -$180K | 0.06% | 257 |
|
|
2025
Q1 | $3.42M | Buy |
49,192
+4,964
| +11% | +$345K | 0.08% | 237 |
|
|
2024
Q4 | $3.8M | Buy |
44,228
+5,393
| +14% | +$464K | 0.09% | 206 |
|
|
2024
Q3 | $4.62M | Buy |
38,835
+906
| +2% | +$108K | 0.13% | 138 |
|
|
2024
Q2 | $5.41M | Sell |
37,929
-649
| -2% | -$92.6K | 0.16% | 112 |
|
|
2024
Q1 | $4.95M | Sell |
38,578
-2,577
| -6% | -$331K | 0.16% | 119 |
|
|
2023
Q4 | $4.26M | Buy |
41,155
+25,179
| +158% | +$2.6M | 0.15% | 135 |
|
|
2023
Q3 | $1.45M | Buy |
15,976
+2,508
| +19% | +$228K | 0.07% | 268 |
|
|
2023
Q2 | $1.09M | Buy |
13,468
+562
| +4% | +$45.5K | 0.05% | 364 |
|
|
2023
Q1 | $1.03M | Sell |
12,906
-566
| -4% | -$45K | 0.06% | 321 |
|
|
2022
Q4 | $912K | Sell |
13,472
-340
| -2% | -$23K | 0.06% | 331 |
|
|
2022
Q3 | $688K | Buy |
13,812
+2,080
| +18% | +$104K | 0.06% | 361 |
|
|
2022
Q2 | $654K | Buy |
11,732
+1,062
| +10% | +$59.2K | 0.05% | 365 |
|
|
2022
Q1 | $592K | Buy |
10,670
+3,224
| +43% | +$179K | 0.04% | 419 |
|
|
2021
Q4 | $417K | Buy |
+7,446
| New | +$417K | 0.03% | 502 |
|
|
2021
Q1 | – | Sell |
-27,274
| Closed | -$953K | – | 362 |
|
|
2020
Q4 | $953K | Buy |
+27,274
| New | +$953K | 0.26% | 83 |
|
|
2020
Q3 | – | Sell |
-62
| Closed | -$2K | – | 513 |
|
|
2020
Q2 | $2K | Buy |
+62
| New | +$2K | ﹤0.01% | 644 |
|